Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KT-253 |
Trade Name | |
Synonyms | KT 253|KT253 |
Drug Descriptions |
KT-253 is a degrader of MDM2, which reduces TP53-dependent increase in MDM2 protein levels and potentially induces apoptosis in tumor cells and inhibits tumor growth (Blood (2022) 140 (Supplement 1): 6239-6240). |
DrugClasses | MDM2 Inhibitor 23 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
KT-253 | KT-253 | 0 | 1 |